CYBB and chronic granulomatous disease: These microbiocidal and tissue-damaging mechanisms, however, cannot account for the more severe immune-mediated tissue inflammation in NOX2-deficient animals (15, 16, 21, 22, 37) and in patients with CGD (38–40).